Interactions between medicines and functional foods or dietary supplements

Keio Journal of Medicine

Volumn 53, Issue 3, 2004, Pages 137-150

  Ohnishi, Noriaki ^a   Yokoyama, Teruyoshi ^a  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Cytochrome P450 (CYP); Dietary supplement; Drug interaction; Functional food; P glycoprotein

Indexed keywords

ACETYLSALICYLIC ACID; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; ANTIVIRUS AGENT; ATORVASTATIN; CALCIUM CHANNEL BLOCKING AGENT; CILOSTAZOL; CYCLOSPORIN; CYTOCHROME P450; CYTOCHROME P450 3A4; ENSURE; FAMOTIDINE; FELODIPINE; GEFITINIB; GLYCOPROTEIN P; HYPERFORIN; HYPERICUM PERFORATUM EXTRACT; IMATINIB; IMMUNOSUPPRESSIVE AGENT; LIPOVITAN D; METHOXSALEN; MEVINOLIN; NEUROLEPTIC AGENT; NIFEDIPINE; NISOLDIPINE; NON PRESCRIPTION DRUG; PIMOZIDE; PRAVASTATIN; SAQUINAVIR; SHIN POPON S; SIMVASTATIN; TACROLIMUS; UNCLASSIFIED DRUG; UNINDEXED DRUG; VICKS MEDICATED DROPS; WARFARIN;

ALTERNATIVE MEDICINE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ASADA AME; BLEEDING; BONE MARROW DEPRESSION; BRAIN HEMORRHAGE; CONTROLLED STUDY; CONVULSION; DIET SUPPLEMENTATION; DIGITALIS INTOXICATION; DRUG BINDING; DRUG CROSS REACTIVITY; DRUG METABOLISM; FOOD ANALYSIS; FOOD DRUG INTERACTION; GASTROINTESTINAL ABSORPTION; HEART DISEASE; HUMAN; HUMAN CELL; HYPERCALCEMIA; HYPERVITAMINOSIS; HYPHEMA; NEPHROTOXICITY; NONHUMAN; PHOTOTOXICITY; RAT; REVIEW; SIDE EFFECT; THROMBOCYTE AGGREGATION;

DIETARY SUPPLEMENTS; FOOD-DRUG INTERACTIONS; HEALTH FOOD; HERB-DRUG INTERACTIONS; HUMANS;

EID: 4844223518     PISSN: 00229717     EISSN: None     Source Type: Journal    
DOI: 10.2302/kjm.53.137     Document Type: Review

References (33)

1. Homma M, Takeda M, Yamamoto Y, Suga H, Horiuchi M, Satoh S, Kohda Y: Consultation and survey for drug interaction in outpatients taking the medicines potentially interact with St. John's Wort. Yakugaku Zasshi 2000; 120: 1435-1440
2. Chiba K: Drug interactions via cytochrome P450. Farumashia 1995; 31: 992-996
3. Guengerich FP: In vitro techniques for studying drug metabolism. J Pharmacokinet Biopharm 1996; 24: 521-533
4. Ohnishi N, Yonekawa Y, Nakasako S, Nagasawa K, Yokoyama T, Yoshioka M, Kuroda K: Studies on interactions between traditional herbal and Western medicines. I. Effects of Sho-seiryuto on the pharmacokinetics of carbamazepine in rats. Biol Pharm Bull 1999; 22: 527-531
5. Ohnishi N, Yonekawa Y, Fumihara T, Nakasako S, Nagasawa K, Yokoyama T, Yoshioka M, Kuroda K: Studies on interactions between traditional herbal and Western medicines. II. Lack of pharmacokinetic interaction between Sho-seiryu-to and carbamazepine in healthy volunteers. Jpn J TDM 1999; 16: 399-404
6. Fugh-Berman A: Herb-drug interactions. Lancet 2000; 355: 134-138
7. Linde K, Ramirez G, Mulrow CD, Pauls A, Weidenhammer W, Melchart D: St John's wort for depression - an overview and meta-analysis of randomised clinical trials. BMJ 1996; 313: 253-258
8. Ernst E: Second thoughts about safety of St John's wort. Lancet 1999; 354: 2014-2016
9. Kaehler ST, Sinner C, Chatterjee SS, Philippu A: Hyperforin enhances the extracellular concentrations of catecholamines, serotonin and glutamate in the rat locus coeruleus. Neurosci Lett 1999; 262: 199-202
10. Ruschitzka F, Meier PJ, Turina M, Luscher TF, Noll G: Acute heart transplant rejection due to Saint John's wort. Lancet 2000; 355: 548-549
11. Piscitelli SC, Burstein AH, Chain D, Alfaro RM, Falloon J: Indinavir concentrations and St John's wort. Lancet 2000; 355: 547-548
12. Nebel A, Schneider BJ, Baker RK, Kroll DJ: Potential metabolic interaction between St. John's wort and theophylline. Ann Pharmacother 1999; 33: 502
13. Roby CA, Anderson GD, Kantor E, Dryer DA, Burstein AH: St John's Wort: effect on CYP3A4 activity. Clin Pharmacol Ther 2000; 67: 451-457
14. Moore LB, Goodwin B, Jones SA, Wisely GB, Serabjit-Singh CJ, Willson TM, Coffins JL, Kliewer SA: St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor. Proc Natl Acad Sci USA 2000; 97: 7500-7502
15. Johne A, Brockmoller J, Bauer S, Maurer A, Langheinrich M, Roots I: Pharmacokinetic interaction of digoxin with an herbal extract from St John's wort (Hypericum perforatum). Clin Pharmacol Ther 1999; 66: 338-345
16. Lilja JJ, Kivisto KT, Neuvonen PJ: Duration of effect of grape-fruit juice on the pharmacokinetics of the CYP3A4 substrate simvastatin. Clin Pharmacol Ther 2000; 68: 384-390
17. Doherty MM, Charman WN: The mucosa of the small intestine: how clinically relevant as an organ of drug metabolism? Clin Pharmacokinet 2002; 41: 235-253
18. Takanaga H, Ohnishi A, Murakami H, Matsuo H, Higuchi S, Urae A, Irie S, Furuie H, Matsukuma K, Kimura M, et al: Relationship between time after intake of grapefruit juice and the effect on pharmacokinetics and pharmacodynamics of nisoldipine in healthy subjects. Clin Pharmacol Ther 2000; 67: 201-214
19. Dresser GK, Bailey DG, Leake BF, Schwarz UI, Dawson PA, Freeman DJ, Kim RB: Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine. Clin Pharmacol Ther 2002; 71: 11-20
20. Lilja JJ, Backman JT, Laitila J, Luurila H, Neuvonen PJ: Itraconazole increases but grapefruit juice greatly decreases plasma concentrations of celiprolol. Clin Pharmacol Ther 2003; 73: 192-198
21. Kobayashi D, Nozawa T, Imai K, Nezu J, Tsuji A, Tamai I: Involvement of human organic anion transporting polypeptide OATP-B (SLC21A9) in pH-dependent transport across intestinal apical membrane. J Pharmacol Exp Ther 2003; 306: 703-708
22. Tomlinson B: Medical View Point 2003; 24: 11
23. Ohnishi N: Interaction Drug and Food, Osaka, Fuji Medical Publishing Co, 2003
24. Yeung PK, Mosher SJ, Quilliam MA, Montague TJ: Species comparison of pharmacokinetics and metabolism of diltiazem in humans, dogs, rabbits, and rats. Drug Metab Dispos 1990; 18: 1055-1059
25. Sutton D, Butler AM, Nadin L, Murray M: Role of CYP3A4 in human hepatic diltiazem N-demethylation: inhibition of CYP3A4 activity by oxidized diltiazem metabolites. J Pharmacol Exp Ther 1997; 282: 294-300
26. Murray M, Butler AM: Enhanced inhibition of microsomal cytochrome P450 3A2 in rat liver during diltiazem biotransformation. J Pharmacol Exp Ther 1996; 279: 1447-1452
27. Yoshisue K, Nagayama S, Shindo T, Kawaguchi Y: Effects of 5-fluorouracil on the drug-metabolizing enzymes of the small intestine and the consequent drug interaction with nifedipine in rats. J Pharmacol Exp Ther 2001; 297: 1166-1175
28. Iwao T, Inoue K, Hayashi Y, Yuasa H, Watanabe J: Metabolic extration of nifedipine during absorption from the rat small intestine. Drug Metab Pharmacokin 2002; 17: 546-553
29. Ohnishi N, Kusuhara M, Yoshioka M, Kuroda K, Soga A, Nishikawa F, Koishi T, Nakagawa M, Hori S, Matsumoto T, et al: Studies on interactions between functional foods or dietary supplements and medicines. I. Effects of Ginkgo biloba leaf extract on the pharmacokinetics of diltiazem in rats. Biol Pharm Bull 2003; 26: 1315-1320
30. Koishi T, Ohnishi N, Hamanaka K, Kara K, Watanabe M, Yoshioka M, Kuroda K, Takara K, Yokoyama T: Interactions between healthy foods and drugs (7). Effects of Ginkgo biloba leaf extract on the metabolism of nifedipine in rats. Jpn J Clin Pharmacol Ther 2003; 34: 97S-98S
31. Ohnishi N, Koishi T, Obata Y, Nakagawa M, Matsumoto T, Tkara K, Yokoyama T, Ohkuni T, Yoshioka M, Kuroda K: Effects of simultaneous administration of Ginkgo biloba leaf extract on the pharmacokinetics of nifedipine in healthy volunteers. J Trad Med 2003; 20 (Suppl): 179
32. Ohnishi N, Nakagawa M, Nishikawa M, Yamashita M, Ohta S, Yoshioka M, Kuroda K, Takara K, Yokoyama T: Studies on interactions between functional foods or dietary supplements and medicines. II. Effects of Agaricus blazei Murill and propolis extract on the pharmacokinetics of diltiazem in rats. FFI J Jpn 2003; 208: 353-360
33. Yoshioka M, Kuroda K, Ohnishi N, Kusuhara M, Nishikawa F, Takara K, Yamashita M, Ohta S, Yokoyama T: Interactions between healthy foods and drugs (6). Effects of Ginkgo biloba leaf extract and Pomegranate juice on the pharmacokinetics of diltiazem in rats. Jpn J Ther Drug Monit 2003; 20: 119-120